| Hans-Günter Meyer-Thompson | HIV
EMA Panel Backs Two New HIV Drugs
EMA Panel Backs Two New HIV Drugs
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of two new oral treatments for adults with HIV-1 infection, Pifeltro and Delstrigo, both from Merck Sharp & Dohme BV.
(...) Pifeltro contains doravirine (100 mg) ... Delstrigo is a once-daily fixed-dose combination of doravirine (100 mg), lamivudine (3TC; 300 mg), and tenofovir disoproxil fumarate (TDF; 245 mg). (Medscape, 21.09.2018)